Vedolizumab Therapy for Refractory Eosinophilic Enteritis: A Case of Success
Inflamm Bowel Dis
.
2023 Jan 5;29(1):e1-e2.
doi: 10.1093/ibd/izac077.
Authors
Guilherme Coutinho Martins Mendes Simões
1
,
Verónica Borges
1
,
Carlos Bernardes
1
,
Jaime Ramos
1
Affiliation
1
Gastroenterology Department, Centro Hospitalar e Universitário Lisboa Central, Lisboa, Portugal.
PMID:
36350976
DOI:
10.1093/ibd/izac077
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Enteritis* / drug therapy
Gastritis*
Humans
Substances
vedolizumab
Antibodies, Monoclonal, Humanized
Supplementary concepts
Eosinophilic enteropathy